IDL Biotech
IDL Biotech Q4: Impressive sales (Redeye)
2020-02-20 11:15
IDL reported significantly higher sales than we had expected for the fourth quarter, growing with 53% YoY. Consequently, IDL showed a positive EBIT on quarterly basis for the first time in a long time.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se